Related Experiment Video
Updated: Apr 28, 2026
03:05
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
1.8K
Gastric cáncer: Overview.
M Blanca Piazuelo1, Pelayo Correa1
1Division of Gastroenterology, Department of Medicine,Vanderbilt University School of Medicine, Nashville, TN, USA.
Colombia Medica (Cali, Colombia)
|June 4, 2014
Summary
Gastric cancer remains a significant global health issue, often diagnosed late. Early detection and Helicobacter pylori treatment are key to improving survival rates for this complex disease.
Area of Science:
- Oncology
- Gastroenterology
- Epidemiology
Background:
- Gastric cancer is a leading cause of cancer incidence and mortality worldwide.
- Most cases are diagnosed at advanced stages, presenting significant clinical challenges and limited treatment options.
- Gastric cancer development is a multifactorial process involving genetic, epigenetic, and environmental factors.
Purpose of the Study:
- To review the epidemiology, etiology, classification, and prevention strategies for gastric cancer.
- To highlight the importance of early detection and risk factor management in improving patient outcomes.
- To emphasize the role of Helicobacter pylori infection and its eradication in gastric cancer prevention.
Main Methods:
- Review of existing literature on gastric cancer epidemiology, risk factors, and histopathology.
- Analysis of classification systems based on histology (intestinal vs. diffuse) and anatomical location (proximal vs. distal).
- Evaluation of current treatment and prevention strategies, including surgical resection and anti-Helicobacter pylori therapy.
Main Results:
- Gastric cancer incidence and mortality remain high globally, despite regional decreases.
- Helicobacter pylori infection, high salt intake, smoking, and genetic factors are key predisposing factors.
- Intestinal type adenocarcinoma follows Correa's cascade, while diffuse type is more aggressive; early-stage surgical resection is the only effective treatment.
- Anti-Helicobacter pylori therapy shows promise as an effective preventive measure.
Conclusions:
- Gastric cancer is a complex disease with multifactorial etiology and varied clinical behavior based on histologic type and location.
- Early detection, risk factor management (including H. pylori eradication), and timely surgical intervention are crucial for improving survival rates.
- Further research and surveillance are needed to combat the global burden of gastric cancer.
Related Concept Videos
01:26Gastritis II: Pathophysiology
43
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
43
01:27Gastritis-I: Introduction and Types
3.7K
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
3.7K
01:21Barrett Esophagus-I: Introduction
1.5K
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
1.5K
01:11Pyloric Obstruction
34
Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
34
01:27Peptic Ulcer
46
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
46
01:25Peptic Ulcer Disease III: Clinical Manifestations and Complications
33
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant...
33